Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04567394 · ClinicalTrials.gov registry record · NA
Cannabis Use Disorder Treatment Study
A NA study, sponsored by The University of Tennessee, Knoxville.
- Active
- Registry status
- NA
- Development phase
- 1,077
- Enrollment target
NCT04567394: Active NA study, sponsored by The University of Tennessee, Knoxville.
NCT04567394 is a NA study that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 1,077 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04567394, a NA study, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,077 participants
- Enrollment target
Study Summary
The purpose of this study is to test a text-delivered counseling program to stop or reduce cannabis use among young adults (ages 18 to 25).
Primary Outcome
Urine THC levels (50ng/mL, 100ng/mL, 200ng/mL, 300ng/mL) will provide a biological measure for current cannabis use.
Interventions
- BEHAVIORAL Peer Network Counseling-txt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,077 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What the registry record for NCT04567394 still lists
NCT04567394 is an interventional study that assigns participants to a tested intervention. Its 1,077 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 1 intervention - of which Peer Network Counseling-txt is the first listed.
NCT04567394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04567394 about?
NCT04567394 is a clinical study titled "Cannabis Use Disorder Treatment Study". The purpose of this study is to test a text-delivered counseling program to stop or reduce cannabis use among young adults (ages 18 to 25).
What is the current status of trial NCT04567394?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,077 participants. The study started on 2019-08-01. Estimated completion is 2026-05-31.
What interventions are being tested in trial NCT04567394?
The interventions under investigation include: Peer Network Counseling-txt (BEHAVIORAL).
Who is sponsoring clinical trial NCT04567394?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04567394's enrollment target sits among peer trials
1,077 95th of 2000 higher than 1,906 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
- NCT07213804 · 1,080 participants · Phase 3
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI